Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cost-effectiveness
100%
Radiation Therapy
100%
Intermediate Risk
100%
Radical Prostatectomy
100%
High-grade Prostate Cancer
100%
Androgen Deprivation Therapy
83%
Quality-adjusted Life Expectancy
50%
Quality-adjusted Life Years
33%
Treatment Strategy
16%
Young Age
16%
Risk Factors
16%
Cardiovascular Risk
16%
Treatment Group
16%
Salvage Therapy
16%
Health Status
16%
Treatment Options
16%
Markov Model
16%
Treatment Toxicity
16%
Multiple Treatments
16%
Cancer Recurrence
16%
Cost-effectiveness Analysis
16%
One-way Sensitivity Analysis
16%
Single Treatment
16%
Life Cost
16%
Adjuvant Radiation
16%
Probabilistic Sensitivity Analysis
16%
Intermediate-risk Prostate Cancer
16%
Biochemical Failure
16%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Prostate Cancer
100%
Prostatectomy
100%
Radiation Therapy
100%
Androgen Deprivation Therapy
83%
Life Expectancy
50%
Health Care Cost
33%
Quality Adjusted Life Year
33%
High Risk Population
16%
Cardiovascular Risk
16%
Salvage Therapy
16%
Health Status
16%
Cancer Recurrence
16%
Biochemical Recurrence
16%
Treatment Group
16%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen
100%
Life Expectancy
60%
Cardiovascular Risk
20%
Health Status
20%
Cancer Recurrence
20%
Treatment Group
20%
Biochemical Recurrence
20%